Plenary Session - inactive due to federal service

397 Folgen

1. 1.17 BONUS! Interpretation of Cancer Clinical Trials

   Vom: 22.10.2018
2. 1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong

   Vom: 17.10.2018
3. 1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare

   Vom: 16.10.2018
4. 1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing

   Vom: 12.10.2018
5. 1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu

   Vom: 8.10.2018
6. 1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology

   Vom: 3.10.2018
7. 1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali

   Vom: 2.10.2018
8. 1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet

   Vom: 25.9.2018
9. 1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints

   Vom: 20.9.2018
10. 1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds

    Vom: 14.9.2018
11. 1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola

    Vom: 11.9.2018
12. 1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority

    Vom: 7.9.2018
13. 1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity

    Vom: 5.9.2018
14. 1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser

    Vom: 30.8.2018
15. 1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross

    Vom: 21.8.2018
16. 1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar

    Vom: 16.8.2018
17. 1.01: Introduction and Dr. Adam Obley

    Vom: 14.8.2018